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antagonists binding to EphB4 will also contribute to
these efforts.
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In this issue of Structure, Scarsdale et al. (2006) report
structures of the Xenopus X29 Nudix decapping
protein, including homodimer structures in complex
with cap nucleotides. These structures reveal insights
into the mechanism of cap substrate recognition and
predict an RNA binding path on the protein surface.
The small nucleolar RNAs (snoRNAs) are a group of non-
coding RNAs that associate with nucleolar proteins
to form small nucleolar ribonucleoprotein particles
(snoRNPs) that play well-established roles in ribosomal
RNA (rRNA) processing. Although over a hundred
snoRNPs are involved in the various rRNA modifica-
tions, only a handful are necessary for cleavage of the
45S pre-rRNAs into the three mature rRNAs. Among
these, the U8 snoRNP is essential for both 5.8S and
28S rRNA production (Peculis and Steitz, 1993). The
U8 snoRNA is transcribed by RNA polymerase II and,
like many small nuclear RNAs and snoRNAs, is subse-
quently hypermethylated at the 50 end to a m2,2,7G trime-
thylated capped RNA.
Initial gel shift analysis of the U8 snoRNA revealed
a 29 kDa polypeptide from Xenopus ovary extract,
termed X29, that specifically bound the RNA (Tomasevic
and Peculis, 1999). The novel protein was identified and
found to contain an evolutionarily conserved Nudix (nu-
cleotide diphosphatase linked to moiety X) motif con-
sisting of an w23 amino acid consensus sequence,
GX5EX7REUXEEXGU, where X denotes any residue
and U represents Ile, Leu, or Val (Mildvan et al., 2005).
Similar to Dcp2, a Nudix protein which hydrolyzes cap-
ped messenger RNA to release m7GDP (known as the
decapping reaction), X29 was also shown to possess de-
capping activity and to decap U8 snoRNA preferentially,
releasing the m2,2,7GDP trimethyl nucleoside diphos-phate (Ghosh et al., 2004). In this issue, Scarsdale et al.
(2006) provide structural insight into the substrate bind-
ing of the X29 Nudix decapping protein to a cap moiety.
Decapping enzymes play well-characterized roles in
mRNA degradation. The crystal structures of the three
known catalytically active decapping enzymes have
now been solved: the scavenger decapping protein
DcpS, the mRNA decapping protein Dcp2, and the nu-
cleolar decapping protein X29 (Gu et al., 2004; Scarsdale
et al., 2006; She et al., 2006). DcpS is distinct in that it
harbors a histidine triad decapping motif, while X29
and Dcp2 are both Nudix-containing proteins. Scarsdale
et al. (2006) report a series of crystal structures for the
homodimeric X29 apo protein and the metal- and nucle-
otide bound X29 holo-protein. The structures confirm
the presence of the characteristic a/b/a sandwich Nudix
fold structure within X29. A comparison of the structural
alignment of X29 with that of the recently reported
amino-terminal fragment of the Schizosaccharomyces
pombeDcp2 monomer reveals conservation in the over-
all Nudix fold structure (Figure 1A). As expected, the
core a helix of the Nudix motif is highly conserved, par-
ticularly in the identical positioning of the critical gluta-
mates previously shown to be essential for X29 and
Dcp2 decapping activities (Coller and Parker, 2004).
The X29 Nudix protein is surprisingly unique among
cap binding proteins structurally characterized thus
far. Previous structural studies have broadly illustrated
that cap substrates insert into a binding pocket that pro-
vides general interactions and specific contacts to the
m7G nucleobase (Marcotrigiano et al., 1997). Common
features of proteins that form a complex with cap analog
are pi-pi stacking via two aromatic residues sandwich-
ing the m7G base, and hydrogen bonding between the
m7G base and the vicinal side chain of an acidic amino
acid, as initially revealed for the eIF4E cap binding
protein (Marcotrigiano et al., 1997). For example, in
the crystal structure of cap bound DcpS, a plethora of
van der Waals, general stacking, and hydrogen bond
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(A) Ribbon diagram for m7GpppA-X29 (ma-
genta) and Dcp2 (blue). The Nudix fold of
an X29 monomer is shown. The a helices of
Dcp2 Nudix motif and Box B are shown.
The m7GpppA (yellow) cap substrate is rep-
resented as a stick model.
(B) A transparent surface representation of
the m7GpppA-X29 homodimer with a ribbon
diagram for the Box Bs of m7GpppA-X29
(magenta) and monomer of Dcp2 (blue) is
shown. The m7GpppA (yellow) cap sub-
strates are represented as stick models.
The red arrows point to the respective m7G
nucleobase exposed to solvent.
(PDB coordinates for X29 and Dcp2 were
kindly provided by J.N. Scarsdale and
H. Song prior to publication, and we thank
C. Lima for assistance with the structure
superimposition).interactions contribute to the stabilization of the com-
plex formation (Gu et al., 2004). However, Scarsdale
et al. (2006) clearly demonstrate that the m7GpppA-
X29 complex is unusual in that the m7G nucleobase is
exposed to the solvent rather than residing within a bind-
ing pocket. Surprisingly, a stacking interaction between
the nucleoside ribose and phenylalanine 49 of X29 rep-
resents the one major contact made between the m7G
base and the enzyme. The observed minimal contact
between the methyl cap nucleobase with X29 and its ex-
posure to the solvent provides an important explanation
for the ability of X29 to recognize and hydrolyze U8
snoRNA substrates irrespective of their cap methyl moi-
ety. The deduced structure is consistent with previous
biochemical experiments demonstrating that X29 hy-
drolyzes a variety of U8 snoRNA substrates that vary
in degree of methylation, including unmethylated, mono-
methylated, and trimethylated capped RNAs (Ghosh
et al., 2004). As a corollary, DcpS preferentially hydro-
lyzes methylated over unmethylated cap structure, indi-
cating that the network of contacts between the m7G
base and the enzyme contributes to the specific sub-
strate recognition (Gu et al., 2004).
An additional interesting note pertains to the carboxyl-
terminal end of the X29 Nudix fold that contains a 20
amino acid stretch initially defined as Box B in Dcp2.
Box B was shown to be necessary for both decapping
and RNA binding activities (Piccirillo et al., 2003). More-
over, the recent Dcp2 crystal structure indicates that the
a-helical Box B is not a distinct domain, but rather an in-
tegral component of the Nudix fold congruent with its re-
quirement for both substrate binding and hydrolysis. De-
spite the lack of an apparent homologous Box B in X29
by sequence, structure-based alignment of the two
Nudix fold domains reveals amino acids 181 to 194 of
X29 form an a helix that superimposes with the Dcp2
Box B (Figure 1). Although the RNA binding site is not
yet known on the X29 homodimer, Scarsdale et al.
(2006) have proposed a binding path for U8 extending
from the cap dinucleotide along a positive surface of
the protein. Consistent with a role for Box B in RNA bind-
ing, the Box B helix seems to lie along this path. Future
site-directed mutagenesis studies should clarify the pre-cise amino acids required for general RNA binding by
Nudix domains as well as for preferential U8 snoRNA
binding demonstrated by X29. Based on the extent of
the overall Nudix fold conservation between X29 and
Dcp2, it is likely that the two proteins will share similar
modes of binding to capped RNA.
The X29 crystal structures represent the first example
of a Nudix decapping protein bound to a cap substrate
and provide meaningful insight into the molecular mech-
anism behind substrate recognition and RNA binding.
However, as the natural substrate for catalysis of this
enzyme is a capped RNA polymer, it is likely that future
cocrystal structures of X29 with capped RNA have the
potential to reveal interesting conformational differ-
ences and even some surprises.
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